NZ224802A - Introducing a drug sensitivity gene into tumour cell by means by a retrovirus - Google Patents

Introducing a drug sensitivity gene into tumour cell by means by a retrovirus

Info

Publication number
NZ224802A
NZ224802A NZ224802A NZ22480288A NZ224802A NZ 224802 A NZ224802 A NZ 224802A NZ 224802 A NZ224802 A NZ 224802A NZ 22480288 A NZ22480288 A NZ 22480288A NZ 224802 A NZ224802 A NZ 224802A
Authority
NZ
New Zealand
Prior art keywords
retrovirus
introducing
tumour cell
drug sensitivity
sensitivity gene
Prior art date
Application number
NZ224802A
Other languages
English (en)
Inventor
Steven Barnard Howell
Inder Verma
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of NZ224802A publication Critical patent/NZ224802A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ224802A 1987-05-28 1988-05-26 Introducing a drug sensitivity gene into tumour cell by means by a retrovirus NZ224802A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712528A GB8712528D0 (en) 1987-05-28 1987-05-28 Gene transfer

Publications (1)

Publication Number Publication Date
NZ224802A true NZ224802A (en) 1991-01-29

Family

ID=10618026

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ224802A NZ224802A (en) 1987-05-28 1988-05-26 Introducing a drug sensitivity gene into tumour cell by means by a retrovirus

Country Status (11)

Country Link
EP (2) EP0293193A3 (da)
JP (1) JPH02503512A (da)
AU (1) AU618749B2 (da)
DK (1) DK34489D0 (da)
FI (1) FI894851A7 (da)
GB (1) GB8712528D0 (da)
IL (1) IL86532A0 (da)
NZ (1) NZ224802A (da)
PT (1) PT87597B (da)
WO (1) WO1988009383A1 (da)
ZA (1) ZA883804B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
US6337209B1 (en) 1992-02-26 2002-01-08 Glaxo Wellcome Inc. Molecular constructs containing a carcinoembryonic antigen regulatory sequence
US6770274B1 (en) * 1990-09-14 2004-08-03 The General Hospital Corporation Viral mutant HSV mediated destruction of neoplastic cells
CA2051289C (en) * 1990-09-14 2002-11-26 Robert L. Martuza Viral mediated destruction of neoplastic cells
IE913929A1 (en) * 1990-11-13 1992-05-20 Immunex Corp Bifunctional selectable fusion genes
US6555370B1 (en) 1990-11-13 2003-04-29 Immunex Corporation Bifunctional selectable fusion genes
DE4444949C1 (de) 1994-12-16 1996-11-21 Deutsches Krebsforsch Vektoren und Viren zur Gentherapie
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
US7306591B2 (en) 2000-10-02 2007-12-11 Novasys Medical, Inc. Apparatus and methods for treating female urinary incontinence

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192658A4 (en) * 1984-07-30 1987-07-13 Salk Inst For Biological Studi RETROVIRAL GENE TRANSFER VECTORS.

Also Published As

Publication number Publication date
AU618749B2 (en) 1992-01-09
GB8712528D0 (en) 1987-07-01
PT87597A (pt) 1988-06-01
IL86532A0 (en) 1988-11-15
EP0386002A1 (en) 1990-09-12
WO1988009383A1 (en) 1988-12-01
AU2125388A (en) 1988-12-21
EP0293193A2 (en) 1988-11-30
JPH02503512A (ja) 1990-10-25
ZA883804B (en) 1990-08-29
EP0293193A3 (en) 1990-09-12
FI894851A0 (fi) 1989-10-13
DK34489A (da) 1989-01-26
PT87597B (pt) 1992-09-30
EP0386002A4 (en) 1990-09-26
FI894851A7 (fi) 1989-11-27
DK34489D0 (da) 1989-01-26

Similar Documents

Publication Publication Date Title
DE3572440D1 (en) Gastro-resistant cylindrical pancreatine-microtablets
GB2178447B (en) A system for cell cultivation in vitro.
AU544440B2 (en) Therapeutic drug assay
CS403391A3 (en) Pharmaceutical
AU1666888A (en) Oxygen sensing pacemaker
GB8506656D0 (en) Pharmaceutical capsules
NZ224186A (en) Incubator tilt mechanism
IL86378A0 (en) Phosphinothricin-resistant gene
NZ224802A (en) Introducing a drug sensitivity gene into tumour cell by means by a retrovirus
HUT48457A (en) Improved capsules
EP0313934A3 (en) Pill divider
EP0311059A3 (en) Cell handling apparatus
GB8822870D0 (en) Cell culture vial
AU106236S (en) Pharmaceutical tablet
EP0212558A3 (en) A radiation sensitizer
EP0290923A3 (en) Incubator
PT85828A (en) Cell transfection
EP0283149A3 (en) A radiation gauge
GB2208053B (en) A preamplifier
GB8624949D0 (en) Feeding drugs
IE872599L (en) Cell transfection
GB2207334B (en) An incubator.
DE3175480D1 (en) Drug assay
IL85117A (en) Nand stack rom array
BG44395A1 (en) Drug plate